News & Events

Read about the latest Gore news and events. Learn about innovative new products and technologies.

News

Article: New Container Protects Bulk Frozen Biopharmaceuticals

Posted March 19, 2019

Two growing trends in pharmaceuticals prompted the development of a new high-performance pouch that addresses the mechanical and purity challenges of packaging a liquid biologic or vaccine that requires low temperatures. The GORE® STA-PURE™ Flexible Freeze Container maintains package integrity after freezing at ‑86 deg C. (‑123 deg F) and minimizes product loss due to package failure due to its durable design.

Press Release

Gore Attending Two Upcoming Biopharmaceutical Conferences in April

Posted March 22, 2019

Visit Booth 70 at BPI Europe in Vienna and Booth 3737 at Interphex in New York City to learn how Gore's innovative technologies help biopharmaceutical manufacturers achieve efficiency and operate reliably.

News

Article: New Container Protects Bulk Frozen Biopharmaceuticals

Posted March 19, 2019

Two growing trends in pharmaceuticals prompted the development of a new high-performance pouch that addresses the mechanical and purity challenges of packaging a liquid biologic or vaccine that requires low temperatures. The GORE® STA-PURE™ Flexible Freeze Container maintains package integrity after freezing at ‑86 deg C. (‑123 deg F) and minimizes product loss due to package failure due to its durable design.

Press Release

Gore to Showcase GORE® ENFORM Biomaterial - A New Synthetic and Absorbable Biomaterial for Abdominal Wall Reconstruction - at the American Hernia Society (AHS) Annual Meeting

Posted March 5, 2019

W. L. Gore & Associates, Inc. (Gore) will showcase its new GORE® ENFORM Biomaterial, a fully synthetic and absorbable biomaterial designed for optimal handling and tissue response, at the AHS annual meeting in Las Vegas on March 11-14, 2019.

Press Release

GORE® TIGRIS® Vascular Stent Demonstrates High Patency Rates at 12 Months in Treating SFA and PPA Occlusive Lesions in Challenging Patients

Posted January 24, 2019

The GORE® TIGRIS® Vascular Stent demonstrated that it is a safe and effective device that can be incorporated into a modern “leave-nothing-behind” treatment algorithm that reserves stent usage for more challenging patients.

Press Release

Gore Celebrates 15th Anniversary of Market-Leading GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement

Posted November 12, 2018

W. L. Gore & Associates, Inc. (Gore) is celebrating the 15th Anniversary of its GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement, a synthetic buttressing material engineered to reduce leaks and bleeding in a variety of minimally-invasive weight loss procedures, including sleeve gastrectomy and gastric bypass.

Press Release

Gore to Highlight Real-World Aortic Data at 45th Annual VEITHsymposium®

Posted November 8, 2018

W. L. Gore & Associates, Inc. (Gore) will highlight data gleaned from its Global Registry for Endovascular Aortic Treatment (GREAT) Study at the 45th Annual Symposium on Vascular and Endovascular Issues, VEITHsymposium® in New York.

Press Release

Gore to Launch GORE™ ImproJect™ Plunger for Pre-Filled Syringes at PDA

Posted October 12, 2018

Gore plans to commercially launch the GORE™ ImproJectTM Plunger for Pre-Filled Syringes at the 2018 PDA’s Universe of Pre-Filled Syringe and Injection Device meeting in Orlando, FL on October 8th.

Press Release

Gore Strengthens Collaborative Relationship with ViaCyte by Investing Additional $10 Million

Posted September 25, 2018

ViaCyte, Inc. and W. L. Gore & Associates, Inc. today announced a $10 million investment by Gore into ViaCyte in the form of a convertible promissory note. This new investment by Gore into ViaCyte follows a similar multimillion‐dollar investment by Gore in May 2017.

Press Release

First Patient in Europe Receives Implant of GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System and Enrolls in Post-Market Registry

Posted September 17, 2018

W. L. Gore & Associates, Inc. (Gore) today announced the first European patient implant of the GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System.

Press Release

Gore Acquires Pipeline Medical Technologies, Inc.

Posted September 6, 2018

W. L. Gore & Associates, Inc. announced the acquisition of Pipeline Medical Technologies, Inc., a privately held medical technology company focused on advancing chordal repair for degenerative mitral regurgitation (DMR) via a transcatheter procedure.

Press Release

Gore Announces Successful Patient Implant of Endovascular Stent Graft for the Ascending Aorta

Posted August 27, 2018

Gore announced the first implant in conjunction with the Gore ARISE Study of the GORE® Ascending Stent Graft, an investigational device and the only endovascular stent graft specifically designed to treat Type A dissections of the ascending aorta.

Press Release

Gore to Launch GORE® STA-PURE™ Flexible Freeze Containers at BioProcess International

Posted August 24, 2018

Gore will debut its new GORE® STA-PURE™ Flexible Freeze Containers at the 2018 BioProcess International Conference and Exhibition (BPI).

Load more news